193 related articles for article (PubMed ID: 11292731)
21. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.
Stutzmann Meier P; Entenza JM; Vaudaux P; Francioli P; Glauser MP; Moreillon P
Infect Immun; 2001 Feb; 69(2):657-64. PubMed ID: 11159952
[TBL] [Abstract][Full Text] [Related]
22. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
[TBL] [Abstract][Full Text] [Related]
23. Differential kinetics and molecular recognition mechanisms involved in early versus late growth phase Staphylococcus aureus cell binding to platelet layers under physiological shear conditions.
George NP; Konstantopoulos K; Ross JM
J Infect Dis; 2007 Aug; 196(4):639-46. PubMed ID: 17624852
[TBL] [Abstract][Full Text] [Related]
24. Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B.
Miajlovic H; Loughman A; Brennan M; Cox D; Foster TJ
Infect Immun; 2007 Jul; 75(7):3335-43. PubMed ID: 17438032
[TBL] [Abstract][Full Text] [Related]
25. Differential binding of biofilm-derived and suspension-grown Staphylococcus aureus to immobilized platelets in shear flow.
George NP; Ymele-Leki P; Konstantopoulos K; Ross JM
J Infect Dis; 2009 Mar; 199(5):633-40. PubMed ID: 19210161
[TBL] [Abstract][Full Text] [Related]
26. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence.
Josefsson E; Higgins J; Foster TJ; Tarkowski A
PLoS One; 2008 May; 3(5):e2206. PubMed ID: 18493318
[TBL] [Abstract][Full Text] [Related]
28.
Herman-Bausier P; Labate C; Towell AM; Derclaye S; Geoghegan JA; Dufrêne YF
Proc Natl Acad Sci U S A; 2018 May; 115(21):5564-5569. PubMed ID: 29735708
[TBL] [Abstract][Full Text] [Related]
29. Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis.
Hair PS; Echague CG; Sholl AM; Watkins JA; Geoghegan JA; Foster TJ; Cunnion KM
Infect Immun; 2010 Apr; 78(4):1717-27. PubMed ID: 20100856
[TBL] [Abstract][Full Text] [Related]
30. Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClfA) that are important for ligand binding.
Hartford OM; Wann ER; Höök M; Foster TJ
J Biol Chem; 2001 Jan; 276(4):2466-73. PubMed ID: 11044451
[TBL] [Abstract][Full Text] [Related]
31. Expression of staphylococcal clumping factor A impedes macrophage phagocytosis.
Palmqvist N; Patti JM; Tarkowski A; Josefsson E
Microbes Infect; 2004 Feb; 6(2):188-95. PubMed ID: 14998517
[TBL] [Abstract][Full Text] [Related]
32. A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics.
Ganesh VK; Rivera JJ; Smeds E; Ko YP; Bowden MG; Wann ER; Gurusiddappa S; Fitzgerald JR; Höök M
PLoS Pathog; 2008 Nov; 4(11):e1000226. PubMed ID: 19043557
[TBL] [Abstract][Full Text] [Related]
33. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A.
O'Brien L; Kerrigan SW; Kaw G; Hogan M; Penadés J; Litt D; Fitzgerald DJ; Foster TJ; Cox D
Mol Microbiol; 2002 May; 44(4):1033-44. PubMed ID: 12010496
[TBL] [Abstract][Full Text] [Related]
34. Matrix-binding proteins of Staphylococcus aureus: functional analysis of mutant and hybrid molecules.
Hartford O; McDevitt D; Foster TJ
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2497-2505. PubMed ID: 10517602
[TBL] [Abstract][Full Text] [Related]
35. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection.
Wolz C; Goerke C; Landmann R; Zimmerli W; Fluckiger U
Infect Immun; 2002 Jun; 70(6):2758-62. PubMed ID: 12010960
[TBL] [Abstract][Full Text] [Related]
36. Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions.
Shenkman B; Varon D; Tamarin I; Dardik R; Peisachov M; Savion N; Rubinstein E
J Med Microbiol; 2002 Sep; 51(9):747-754. PubMed ID: 12358065
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus.
Dhawan VK; Yeaman MR; Cheung AL; Kim E; Sullam PM; Bayer AS
Infect Immun; 1997 Aug; 65(8):3293-9. PubMed ID: 9234789
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.
Dominiecki ME; Weiss J
Infect Immun; 1999 May; 67(5):2299-305. PubMed ID: 10225887
[TBL] [Abstract][Full Text] [Related]
39. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
[TBL] [Abstract][Full Text] [Related]
40. Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets.
Miajlovic H; Zapotoczna M; Geoghegan JA; Kerrigan SW; Speziale P; Foster TJ
Microbiology (Reading); 2010 Mar; 156(Pt 3):920-928. PubMed ID: 20007649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
